Login or sign up
For business

Satellos bioscience inc.

4.0· 9 reviews
Average ratingGreat
4.0/ 5

Based on 9 reviews

533%
433%
333%
20%
10%
Ask AI

Questions about Satellos bioscience inc.

Based on 9 reviews, listing data and website checks · updated 3 days ago

What is Satellos bioscience inc.?

SATELLOS was founded in 2018 as a partnership among Dr. Michael Rudnicki, CEO of the Stemcell Network of Canada, Bloom Burton & Co., and Mr. Frank Gleeson, a serial biotech entrepreneur. The company focuses on regenerative medicine with an initial program in Duchenne Muscular Dystrophy, aiming to restore muscle regeneration through pharmacologically modulating stem cell polarity.

What is the lead drug candidate and how does it work?

The company is developing forazapadin (SAT-3247), an oral small molecule therapy designed to enhance the signals that guide muscle stem cells to divide asymmetrically. By selectively inhibiting AAK1, the drug aims to reset polarity and restore the muscle's natural repair process for conditions like Duchenne muscular dystrophy and facioscapulohumeral muscular dystrophy.

Where is the company based and what industry does it belong to?

SATELLOS is located at 15 Allstate Parkway, Suite 600 in Markham, ON L3R5B4, Canada, though its business profile lists an address at 65 front street east in Toronto. The company operates in the biotechnology industry and serves patients living with devastating muscle diseases by developing therapies that help improve the body's natural repair process.

What is the current rating and what do reviewers say?

The Trustburn rating is 4 out of 5 from 9 reviews, with a split of mostly 5-star and 4-star ratings. Reviewers consistently praise the excellent quality of products, friendly and helpful customer service, user-friendly website, and straightforward ordering process, while noting fast shipping and a wide range of options.

What investment and financial news has been reported?

Investment news from February 2026 mentions that CureDuchenne invested in Satellos as it raised $57.2M to advance its Duchenne program through clinical trials. Additionally, financial news outlets reported GAAP EPS of -$0.53 as of November 2026, highlighting the company's financial results during that period.

What scientific advisory board was recently established?

The company established a Scientific Advisory Board in October 2026 to explore the biology of regeneration in aging and neuroscience. This board includes distinguished scientists with expertise spanning stem cell biology, regenerative medicine, aging research, neuroscience, and small molecule chemistry.

What are the stock tickers and social media handles?

SATELLOS is traded on NASDAQ under the ticker MSLE and on the TSX under MSCL. The company also maintains a presence on social media platforms including LinkedIn, Instagram, and X, where it shares updates about its mission and progress.

Who are the key executives and board members?

The company's leadership includes Frank Gleeson as CEO and co-founder, Michael Rudnicki as Chief Discovery Officer, and Elizabeth Williams as CFO. The board of directors includes notable figures such as Geoff MacKay, Franklin M. Berger, and Brian Bloom, reflecting a strong industry background.

What is the core scientific approach?

The company's approach involves studying the signals that guide regeneration, with a focus on restoring muscle stem cell function. This strategy aims to address multiple degenerative muscle diseases by re-establishing asymmetric division, which is critical for muscle repair and regeneration.

What are the current clinical stages and indications?

SATELLOS is currently in the clinical stage, with its lead program targeting Duchenne Muscular Dystrophy and expanding to facioscapulohumeral muscular dystrophy. The company is actively pursuing regulatory approvals and expects topline data from its BASECAMP Phase 2 Pediatric Study in early 2027.

What is the stated mission and goal?

The company's mission is to improve the lives of people living with devastating muscle diseases by restoring the body's natural ability to regenerate muscle. This goal is achieved through the development of forazapadin, which targets AAK1 to enhance muscle stem cell activity.

How can I contact Satellos bioscience inc.?

You can reach Satellos bioscience inc. by e-mail at info@satellos.com.

What is the official website of Satellos bioscience inc.?

The official website of Satellos bioscience inc. is satellos.com.

AI-generated from reviews on this page. Verify anything important with the company directly.

Deanna Milton
Reviews 1

😊 I've been a customer of Satellos bioscience inc. for quite some time now and I must say they never disappoint. The quality of their products is excellent and the customer service is always friendly and helpful. I would highly recommend them to anyone in need of bioscience supplies!

Hollis Lawrence
Reviews 1

I had a great experience with Satellos bioscience inc. The products they offer are of excellent quality and they have a wide range of options to choose from. The customer service is also top-notch and the staff is very knowledgeable and helpful. I highly recommend Satellos for all your bioscience needs!

Nigel Winnington
Reviews 1

🌟 Satellos bioscience inc. is a wonderful company to deal with. Their products are of great quality and the customer service is exceptional. I love the variety of options they offer and their website is very user-friendly. I'm very satisfied with my overall experience with Satellos!

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website — a simple way to convert your visitors into customers.

Get the widget for your site →

About Satellos bioscience inc.

Satellos Bioscience is a regenerative medicine company formed in 2018 as a partnership among Dr. Michael Rudnicki, one of the country’s foremost stem cell scientists and CEO of the Stemcell Network of Canada, Bloom Burton & Co. – the nation’s largest healthcare investment bank -- and Mr. Frank Gleeson, a serial biotech entrepreneur and former healthcare VC. Satellos has recently completed a seed round of financing to pursue its unique approach of pharmacologically modulating stem cell polarity to stimulate in vivo tissue repair and regeneration. Our initial focus is muscle regeneration, a field in which Dr. Rudnicki is a world leader, with a lead program in Duchenne Muscular Dystrophy.

Address
65 front street east
Categories
Biotechnology